Opioid Addiction and Codeine Dependence

Clinical Scenario

Michael Patterson, 45, calls requesting his codeine prescription early, claiming he is going away. His records show multiple early prescription requests over six months, previous tramadol use, and escalating pain complaints. He has chronic lower back pain from a workplace injury, is on sertraline for depression, is unemployed, and recently divorced with financial difficulties.

What This Case Tests

Recognising patterns of opioid dependence from prescription records; conducting a non-judgmental addiction assessment; managing the immediate request while building a therapeutic relationship; identifying psychosocial deterioration as evidence of addiction impact; creating a collaborative treatment plan including harm reduction.

Common Mistakes Trainees Make

The three most common mistakes are: either giving the early prescription to avoid confrontation (enabling further dependence) or bluntly refusing without exploring what is really happening (which shuts down the conversation). The third critical error is failing to ask about other opioid sources — this patient obtains codeine from a friend, buys OTC preparations from multiple pharmacies, and orders tramadol online. Trainees also frequently miss the alcohol use, which combined with opioids creates serious overdose risk.

The Consultation Challenge

This case presents a patient who has developed dependence on over-the-counter codeine, often purchased from pharmacies without a prescription. The consultation tests your ability to identify and manage opioid dependence in primary care — a scenario that is increasingly common and frequently examined.

The patient is likely to minimise their use or present with a related symptom (headaches, pain) rather than directly disclosing codeine dependence. Strong Data Gathering means looking for the hidden agenda: escalating doses, purchasing from multiple pharmacies, withdrawal symptoms between doses, and functional impairment.

The critical distinction is between dependence and recreational misuse. Codeine dependence often begins with legitimate pain management and escalates gradually — the patient may not recognise it as addiction. Your approach should reflect this: validating their experience of pain while gently exploring the pattern of escalating use.

Management requires knowledge of the opioid dependence pathway. For codeine dependence, options include supported gradual reduction in primary care, referral to local drug and alcohol services, and consideration of opioid substitution therapy for severe dependence. You also need to address the underlying pain condition that initiated the codeine use.

A common trap is focusing exclusively on stopping the codeine without addressing what the patient will use for pain relief instead. Demonstrating that you understand the patient needs both an addiction management plan and a pain management plan shows clinical maturity.

Time check: Use the first 4 minutes to take a thorough substance use history including amount, frequency, escalation pattern, and withdrawal symptoms. By minute 6, address the dependence directly with a non-judgmental framing. Use the remaining time for a collaborative reduction plan with clear follow-up.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners look for a systematic substance use history: current dose, frequency, duration, route of acquisition (pharmacy, online), escalation pattern, previous quit attempts, and withdrawal symptoms. You should screen for co-existing substance use (alcohol, other analgesics) and assess the underlying pain condition. Crucially, examiners assess whether you identify the dependence through targeted questioning rather than accepting the patient's presenting complaint at face value.

Clinical Management and Medical Complexity: This is the high-scoring domain. Examiners expect you to explain codeine dependence as a medical condition, not a lifestyle choice. They look for a structured management plan: supported gradual reduction with a clear tapering schedule, referral to drug and alcohol services if appropriate, alternative pain management (non-opioid analgesics, physiotherapy, pain clinic referral), and a follow-up schedule with accountability. Knowledge of codeine's ceiling dose, the risks of combination products (codeine/paracetamol or codeine/ibuprofen causing organ damage), and when to consider specialist referral are all assessed.

Relating to Others: Addiction carries significant stigma, and examiners assess whether your approach is non-judgmental. Do you validate the patient's pain? Do you explain dependence in a way that removes blame? Do you involve the patient in their treatment plan rather than dictating it? The consultation should feel collaborative, not punitive.

Example Opening

If the patient presents with their underlying pain: "I'd like to understand your pain better. Can you tell me what you've been using to manage it, and how often? Sometimes when pain has been going on for a while, the treatments themselves can start causing their own problems."

This opening gently steers toward exploring medication use without making the patient feel accused.

When naming the dependence: "What you're describing — needing more and more to get the same effect, feeling unwell when you miss a dose — that's actually a recognised medical pattern called dependence. It doesn't mean you've done anything wrong. It means your body has adapted to the codeine, and we need to help it readjust safely."

Avoid: "How much codeine are you actually taking?" (interrogative tone that puts the patient on the defensive).

How This Appears in the SCA

Addiction cases test your ability to balance empathy with clinical boundaries. Examiners assess whether you can identify dependence without being judgmental, manage the immediate request safely, and demonstrate awareness of harm reduction principles.

Key Statistic

Prescription opioid dependence affects an estimated 500,000 people in England, with codeine-containing products being the most commonly misused. Only 1 in 4 people with opioid dependence currently accesses treatment services.

Relevant Guidelines

• NICE CG173: Neuropathic pain
• NICE NG215: Medicines associated with dependence or withdrawal symptoms
• NICE CG52: Drug misuse in over 16s — opioid detoxification.

Frequently Asked Questions

How do I raise codeine dependence without offending the patient?

Frame dependence as a medical phenomenon, not a moral failing. Use language like "your body has become used to the codeine" rather than "you're addicted." Many patients with codeine dependence started with legitimate pain — acknowledging this validates their experience while opening the door to discussing the pattern of escalating use. Examiners assess your ability to name the problem without destroying rapport.

What is the difference between codeine dependence and recreational opioid misuse?

In the SCA context, codeine dependence typically develops from therapeutic use for genuine pain. The patient escalates doses because tolerance develops, not for euphoria. Recreational misuse involves using opioids primarily for their psychoactive effects. The distinction matters because the management approach differs — dependence patients need both addiction support and alternative pain management, while the underlying pain condition must not be dismissed.

What are the risks of long-term over-the-counter codeine use?

Combination products (co-codamol, Nurofen Plus) carry specific organ damage risks: paracetamol-containing products cause liver toxicity, ibuprofen-containing products cause renal impairment and GI bleeding. Additionally, chronic opioid use causes opioid-induced hyperalgesia (paradoxically making pain worse), constipation, hormonal disruption, and cognitive impairment. These specific risks should be part of your counselling in the consultation.

Should I refer to drug and alcohol services or manage in primary care?

NICE guidance supports primary care management for mild-to-moderate opioid dependence through supervised gradual reduction. Referral to specialist services is indicated for severe dependence, failed primary care reduction attempts, co-existing mental health problems, or polysubstance use. In the SCA, demonstrating that you know when to manage and when to refer shows clinical judgment.

What alternative pain management should I offer?

The examiner expects you to address the pain that initiated the codeine use. Options include regular paracetamol or NSAIDs at therapeutic doses, physiotherapy referral, pain clinic referral for chronic pain, CBT for pain (evidence-based for chronic pain management), and consideration of non-opioid medications like amitriptyline or gabapentin depending on the pain type. Leaving the patient without a pain management plan is a common and costly mistake.